ALBERT RIDDLE: Open Payments
NPI 1699724880 · HAWORTH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87,370 in 134 payments from 3 companies in 2025. Trend: 2023 $101,540 · 2024 $68,454 · 2025 $87,370
Speaker / faculty: $45,276Consulting: $21,994Travel & lodging: $17,345Food & beverage: $2,756
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 76 | $57,265 |
| ACADIA Pharmaceuticals Inc | 57 | $30,075 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
Products named: INGREZZA, NUPLAZID, REXULTI.
Industry payments across NJ — which companies pay providers there.
